Skip to content

Feasibility of laboratory monitoring in community pharmacy by point of care testing of creatinine and potassium in ambulatory elderly at risk for impaired renal function

Feasibility of laboratory monitoring in community pharmacy by point of care testing of creatinine and potassium in ambulatory elderly at risk for impaired renal function - Testing renal function in community pharmacy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON34595
Enrollment
45
Registered
2010-12-28
Start date
2011-02-07
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired renal function

Interventions

Subjects visiting the pharmacy will be asked to participate for POC-testing creatinine and potassium by use of a finger prick. POC-testing is only done when the MDRD is not known at the GP*s. Based

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Eldery 70 years old or older, under treatment by their own GP. Users on maintenance therapy for diabetis and/or cardiovascular diseases for which therapy adjustments are necessary in case of impaired renal function ambulatory

Exclusion criteria

Exclusion criteria: MDRD =

Design outcomes

Primary

MeasureTime frame
Feasibility of laboratory monitoring in community pharmacies by Point-Of-Care testing creatinine and potassium in ambulatory elderly at risk for impaired renal function. Evaluation of experiences of the patients, pharmacy employees and GPs by a questionnaire.

Secondary

MeasureTime frame
1. Number of approved pharmacist advices by the total number of pharmacist advices after POC-testing 2. Number of subjects with POC-testing by total number of included subjects 3. Number of subjects with impaired renal function ( 6.0 mmol/l; normal: 3.5 - 5.0 mmol/l; hypokalemia:

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)